Intrathecal therapy for chronic pain: current trends and future needs (Q38171395)

30 August 2017

Intrathecal therapy for chronic pain: current trends and future needs (English)

1 reference

30 August 2017

0 references

Salim M Hayek

1

1 reference

30 August 2017

Michael C Hanes

series ordinal

2

1 reference

30 August 2017

language of work or name

English

0 references

publication date

1 January 2014

1 reference

Current Pain and Headache Reports

30 August 2017

1 reference

30 August 2017

18

1 reference

30 August 2017

1

1 reference

30 August 2017

388

1 reference

https://scigraph.springernature.com/pub.10.1007/s11916-013-0388-x

30 August 2017

0 references

cites work

Versuche über Cocainisirung des Rückenmarkes

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Stereospecific and Nonspecific Interactions of the Morphine Congener Levorphanol in Subcellular Fractions of Mouse Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Opiate Receptor: Demonstration in Nervous Tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Relief of continuous chronic pain by intraspinal narcotics infusion via an implanted reservoir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Intraspinal morphine for chronic pain: a retrospective, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Chronic intrathecal morphine for intractable pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

The influence of pulse and respiration on spinal cerebrospinal fluid pulsation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Concentration gradients for HVA, 5-HIAA, ascorbic acid, and uric acid in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Cerebrospinal fluid and spinal cord distribution of baclofen and bupivacaine during slow intrathecal infusion in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Understanding the physiology and pharmacology of epidural and intrathecal opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Comparative spinal distribution and clearance kinetics of intrathecally administered morphine, fentanyl, alfentanil, and sufentanil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Recent insights into the pharmacokinetics of spinal opioids and the relevance to opioid selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Polyanalgesic Consensus Conference 2012: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Mortality associated with implantation and management of intrathecal opioid drug infusion systems to treat noncancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Medical practice perspective: identification and mitigation of risk factors for mortality associated with intrathecal opioids for non-cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Age-dependent intrathecal opioid escalation in chronic noncancer pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Combination of intrathecal opioids with bupivacaine attenuates opioid dose escalation in chronic noncancer pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Management of intrathecal catheter-tip inflammatory masses: an updated 2007 consensus statement from an expert panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Time course and role of morphine dose and concentration in intrathecal granuloma formation in dogs: a combined magnetic resonance imaging and histopathology investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Polyanalgesic Consensus Conference--2012: consensus on diagnosis, detection, and treatment of catheter-tip granulomas (inflammatory masses).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Management of symptomatic intrathecal catheter-associated inflammatory masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Role of Spinal Opioid Receptors in the Antinociceptive Interactions Between Intrathecal Morphine and Bupivacaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

On the ropivacaine-reducing effect of low-dose sufentanil in intrathecal labor analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Adding sufentanil to levobupivacaine or ropivacaine intrathecal anaesthesia affects the minimum local anaesthetic dose required

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Intrathecal coadministration of bupivacaine diminishes morphine dose progression during long-term intrathecal infusion in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Efficacy and Safety of Intrathecal Opioid/Bupivacaine Mixture in Chronic Nonmalignant Pain: A Double Blind, Randomized, Crossover, Multicenter Study by the National Forum of Independent Pain Clinicians (NFIPC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Intrathecal ropivacaine in rabbits: pharmacodynamic and neurotoxicologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

A comparison of the neurotoxic effects on the spinal cord of tetracaine, lidocaine, bupivacaine, and ropivacaine administered intrathecally in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Continuous infusion of opioid and bupivacaine by externalized intrathecal catheters in long-term treatment of "refractory" nonmalignant pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Ziconotide: a review of its pharmacology and use in the treatment of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Intrathecal ziconotide in the treatment of chronic nonmalignant pain: a randomized, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Intrathecal ziconotide for severe chronic pain: safety and tolerability results of an open-label, long-term trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Increased risk of suicide under intrathecal ziconotide treatment? - a warning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Intrathecal administration of clonidine attenuates spinal neuroimmune activation in a rat model of neuropathic pain with existing hyperalgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Pharmacology and toxicology of chronically infused epidural clonidine.HCl in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Preclinical work leading to the development of spinal analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Depression, night terrors, and insomnia associated with long-term intrathecal clonidine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Intrathecal morphine for chronic benign pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Programmable intrathecal opioid delivery systems for chronic noncancer pain: a systematic review of effectiveness and complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Disease-specific and generic health outcomes: a model for the evaluation of long-term intrathecal opioid therapy in noncancer low back pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Pain and its treatment in outpatients with metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Epidural and intrathecal analgesia is effective in treating refractory cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Patient selection and trial methods for intraspinal drug delivery for chronic pain: a national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

A Prospective, Randomized Trial of Intrathecal Injection vs. Epidural Infusion in the Selection of Patients for Continuous Intrathecal Opioid Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Role of pretrial systemic opioid requirements, intrathecal trial dose, and non-psychological factors as predictors of outcome for intrathecal pump therapy: one clinician's experience with lumbar postlaminectomy pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Complications of intrathecal drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Prevention of intrathecal drug delivery catheter-related complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Polyanalgesic Consensus Conference--2012: recommendations on trialing for intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

In situ treatment of an infected intrathecal baclofen pump implant with gentamicin-impregnated collagen fleece

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Prophylaxis and treatment of implant-related infections by local application of antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Patient-controlled analgesia in chronic pain patients: experience with a new device designed to be used with implanted programmable pumps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Patient-controlled Analgesia in Intrathecal Therapy for Chronic Pain: Safety and Effective Operation of the Model 8831 Personal Therapy Manager with a Pre-implanted SynchroMed Infusion System.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

The effects of detoxification, relaxation, and brief supportive therapy on chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-013-0388-X

Predictive value of intrathecal narcotic trials for long-term therapy with implantable drug administration systems in chronic non-cancer pain patients

21 January 2018

1 reference

12 December 2020

Sites of action of subarachnoid lidocaine and tetracaine: observations with evoked potential monitoring during spinal cord stimulator implantation

1 reference

12 December 2020

Implantable intrathecal pumps for chronic pain: highlights and updates

1 reference

12 December 2020

Intrathecal opioids, potency and lipophilicity

1 reference

12 December 2020

Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Results from a morphine:bupivacaine dose regimen of 0.5:4.75 mg/ml.

1 reference

12 December 2020

Pain Relief by Intrathecally Applied Morphine in Man

1 reference

12 December 2020

Chronically infused intrathecal morphine in dogs

1 reference

12 December 2020

Intrathecal ropivacaine for labor analgesia: a comparison with bupivacaine.

1 reference

12 December 2020

Intraspinal narcotic analgesia in the treatment of chronic pain

1 reference

12 December 2020

Repeated intrathecal administration of ropivacaine causes neurotoxicity in rats.

1 reference

12 December 2020

Patient selection and outcomes using a low-dose intrathecal opioid trialing method for chronic nonmalignant pain.

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of intrathecal ziconotide in chronic pain patients

1 reference

12 December 2020

Intrathecal "microdosing": reality or artifact?

1 reference

12 December 2020

Analgesia Produced by a Spinal Action of Morphine and Effects upon Parturition in the Rat

1 reference

12 December 2020

Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival

1 reference

12 December 2020

Effect of anatomical fine structure on the flow of cerebrospinal fluid in the spinal subarachnoid space

1 reference

12 December 2020

A prospective study of catheter-related complications of intrathecal drug delivery systems

1 reference

12 December 2020

Origin of subarachnoid cerebrospinal fluid pulsations: a phase-contrast MR analysis

1 reference

12 December 2020

Chronic pain exacerbated by long-term narcotic use in patients with nonmalignant disease: clinical syndrome and treatment

1 reference

12 December 2020

Hemodynamically independent analysis of cerebrospinal fluid and brain motion observed with dynamic phase contrast MRI

1 reference

12 December 2020

Interaction of intrathecal morphine with bupivacaine and lidocaine in the rat

1 reference

12 December 2020

Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin.

1 reference

12 December 2020

10.1007/S11916-013-0388-X

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

0 references

1 reference